Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813111 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation
A Phase 3 study, sponsored by Pacira Pharmaceuticals.
- Terminated
- Registry status
- Phase 3
- Development phase
- 136
- Enrollment target
NCT00813111 is a Phase 3 study that was terminated before completion, run by Pacira Pharmaceuticals. The registered enrollment target is 136 participants.
The verdict
NCT00813111, a Phase 3 study, was terminated before completion, sponsored by Pacira Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 136 participants
- Enrollment target
Study Summary
The purpose of this study is to provide a more effective postoperative method of pain control for patients undergoing cosmetic sub-muscular breast augmentation. Appropriate postoperative pain management contributes to faster patient mobilization, shortened hospital stays, and reduced healthcare costs.
Interventions
- DRUG Bupivacaine HCl
- DRUG SKY0402
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813111
The ClinicalTrials.gov registry entry for NCT00813111 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine HCl is the first listed.
NCT00813111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813111 about?
NCT00813111 is a clinical study titled "Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation". The purpose of this study is to provide a more effective postoperative method of pain control for patients undergoing cosmetic sub-muscular breast augmentation. Appropriate postoperative pain management contributes to faster patient mobilization, shortened hospital stays, and reduced healthcare cost...
What is the current status of trial NCT00813111?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 136 participants. The study started on 2008-11. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00813111?
The interventions under investigation include: Bupivacaine HCl (DRUG), SKY0402 (DRUG).
Who is sponsoring clinical trial NCT00813111?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.